Compare Applied Digital Corporation (APLD) vs Pfizer Inc (PFE) Price & Performance

Applied Digital (APLD) trades at $31.15, down 3.53% today, amid bearish technical signals despite unanimous analyst buy ratings. The company shows strong revenue growth with $144M in 2025 and $319M projected for 2026, but remains unprofitable with negative margins. Recent news highlights APLD's pivot to AI data centers with $36B in contracted lease value, though execution risks and customer concentration persist.

Outlook: High growth potential from AI infrastructure expansion contrasts with profitability challenges and heavy capital spending. Risks include customer concentration and debt load, but analyst consensus targets $76.67 suggest significant upside if execution improves.

Pfizer (PFE) trades at $24.17, down 0.33% over the past day, with a bearish technical signal from moving averages. The company maintains solid profitability with a net income margin of 11.83% and has beaten EPS estimates in three consecutive quarters. Recent news highlights pipeline advancements in obesity and oncology, with a dividend yield supported by consistent payouts.

Outlook remains mixed; analyst consensus suggests 15% upside to the $27.71 price target, but patent cliffs and revenue normalization post-COVID pose risks. The stock presents value at a P/E of 18.45, though investor sentiment is cautious amid competitive pressures and debt levels near 30% of assets.